RT Journal Article
SR Electronic
T1 Response to: ‘Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis’ by Wallace <em>et al</em>
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP annrheumdis-2019-215036
DO 10.1136/annrheumdis-2019-215036
A1 Andreas Kronbichler
A1 Julia Kerschbaum
YR 2019
UL http://ard.bmj.com/content/early/2019/01/30/annrheumdis-2019-215036.abstract
AB